{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:17:00Z","timestamp":1793593020980,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010519","name":"LSU Health New Orleans","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:52:13Z","timestamp":1623459133000},"page":"4099-4107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans"],"prefix":"10.1016","volume":"39","author":[{"given":"Abby L.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonothan Rosario","family":"Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.001_b0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro752","article-title":"The biology of mating in Candida albicans","volume":"1","author":"Johnson","year":"2003","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.001_b0010","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attriutable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.001_b0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00005373-199912000-00009","article-title":"Synergistic effects of Candida and Escherichia coli on gut barrier function","volume":"47","author":"Diebel","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2021.06.001_b0020","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/pmic.200400903","article-title":"Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies","volume":"4","author":"Pitarch","year":"2004","journal-title":"Proteomics"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.001_b0025","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/JCM.02018-07","article-title":"Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis","volume":"46","author":"Clancy","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.001_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vaccine.2015.11.035","article-title":"Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis","volume":"34","author":"Xin","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.001_b0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mbo3.331","article-title":"Fructose-1,6-bisphosphate aldolase of Neissera meningitidisbinds human plasminogen via its C-terminal lysine residue","volume":"5","author":"Shams","year":"2016","journal-title":"Microbiology Open"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.001_b0040","doi-asserted-by":"crossref","first-page":"e0111108","DOI":"10.1371\/journal.pone.0111108","article-title":"Methionine biosynthesis is essential for infection in the rice blast fungal Magnaporthe oryzae","volume":"10","author":"Saint-Macary","year":"2015","journal-title":"PLoS ONE"},{"issue":"48","key":"10.1016\/j.vaccine.2021.06.001_b0045","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1021\/bi501141t","article-title":"Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase","volume":"53","author":"Capodagli","year":"2014","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.001_b0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1046\/j.1365-2958.2003.03390.x","article-title":"Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins","volume":"47","author":"Crowe","year":"2003","journal-title":"Mol Micro"},{"issue":"253","key":"10.1016\/j.vaccine.2021.06.001_b0055","article-title":"Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia","volume":"13","author":"Li","year":"2013","journal-title":"Biomed Infect Dis"},{"issue":"1343","key":"10.1016\/j.vaccine.2021.06.001_b0060","article-title":"Candida albicans Shaving to Profile Human Serum Proteins on Hyphal Surface","volume":"6","author":"Marin","year":"2015","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.001_b0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/mmy\/myy122","article-title":"Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine","volume":"57","author":"Xin","year":"2019","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.001_b0070","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide Vaccine: Progress and Challenges","volume":"13","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.001_b0075","first-page":"884","article-title":"Development of vaccines for Candida albicans: fighting a skilled transformer","volume":"11","author":"Cassone","year":"2013","journal-title":"Nat Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.001_b0080","doi-asserted-by":"crossref","first-page":"e10000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2021.06.001_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.181.1.405","article-title":"Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell","volume":"181","author":"Mukherjee","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2021.06.001_b0090","first-page":"307","article-title":"The role of complement and antibody in opsonization and intracellular killing of Candida albicans","volume":"57","author":"Pereira","year":"1984","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.001_b0095","article-title":"Double Chimeric Peptide Vaccine and Monoclonal Antibodies that Protect Against Disseminated Candidiasis","volume":"5","author":"Xin","year":"2014","journal-title":"J. Vaccines Vaccination"},{"key":"10.1016\/j.vaccine.2021.06.001_b0100","unstructured":"Xin H, Cutler JE. Inventors; Peptide and conjugate vaccines for fungal infections. LA patent US9416173B2; 2016 Aug 16."},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.001_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035106","article-title":"Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis","volume":"7","author":"Xin","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.001_b0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00736-14","article-title":"The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice","volume":"22","author":"Wegmann","year":"2015","journal-title":"Clin Vaccine Immun"},{"key":"10.1016\/j.vaccine.2021.06.001_b0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10408418709104451","article-title":"Cell wall of Candida albicans and host response","volume":"15","author":"Cassone","year":"1987","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2021.06.001_b0120","doi-asserted-by":"crossref","unstructured":"Conti HR, Huppler AR, Whibley N, Gaffen SL. Animal Models for Candidiasis. Current Protocols in immunology 2014;105(19):19.6.1.-19.6.17.","DOI":"10.1002\/0471142735.im1906s105"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.001_b0125","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1128\/IAI.72.10.5868-5876.2004","article-title":"Dysregulated inflammatory resopnse to Candida albicans in a C5-deficient mouse strain","volume":"72","author":"Mullick","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.001_b0130","first-page":"987","article-title":"Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a","volume":"16","author":"Morser","year":"2018","journal-title":"J Thrombosis Haemotosis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.001_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.001_b0140","doi-asserted-by":"crossref","first-page":"e0148701","DOI":"10.1371\/journal.pone.0148701","article-title":"Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant","volume":"11","author":"Rady","year":"2016","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.001_b0145","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","article-title":"Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis","volume":"18","author":"Xin","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2021.06.001_b0150","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.167.3.1550","article-title":"Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental hematogenously disseminated candidiasis","volume":"167","author":"Han","year":"2001","journal-title":"J Immunol"},{"issue":"93","key":"10.1016\/j.vaccine.2021.06.001_b0155","article-title":"The first isolate of Candida auris in China: clinical and biological aspects","volume":"7","author":"Wang","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2021.06.001_b0160","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.vaccine.2012.12.083","article-title":"A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines","volume":"31","author":"Yano","year":"2012","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2021.06.001_b0165","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2021.06.001_b0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/gt.2013.81","article-title":"The effectof helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization","volume":"2","author":"Smahel","year":"2014","journal-title":"Gene Ther"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2021.06.001_b0175","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0264-410X(99)00255-8","article-title":"The antigenic and immunogenic properties of synthetic peptide immunocontraceptive vaccine candidates based on gamete antigens","volume":"18","author":"Sadler","year":"1999","journal-title":"Vaccine"},{"issue":"64","key":"10.1016\/j.vaccine.2021.06.001_b0180","article-title":"Long-Lasting Mucosal and Systemic Immunity against Influenza is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Musocal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice","volume":"3","author":"Hinkula","year":"2019","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.001_b0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chom.2016.10.003","article-title":"IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae","volume":"20","author":"Chen","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2021.06.001_b0190","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.200425719","article-title":"Decision criteria for resolving isotype switching conflicts by B cells","volume":"35","author":"Deenick","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2021.06.001_b0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0161-5890(84)90103-2","article-title":"Binding of complement subcomponent C1q to mouse IgG1, IgG2a, and IgG2b: a novel C1q binding assay","volume":"4","author":"Leatherbarrow","year":"1984","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2021.06.001_b0200","first-page":"12187","article-title":"Characterization of the antifungal functions of a WGA-Fc(IgG2a) fusion protein to cell wall chitin oligomers","volume":"7","author":"Liedke","year":"2017","journal-title":"Nat Sci Rep"},{"key":"10.1016\/j.vaccine.2021.06.001_b0205","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/clinids\/22.3.462","article-title":"Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer","volume":"22","author":"Blumberg","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.001_b0210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/IAI.74.1.390-393.2006","article-title":"Complement and Fc Function Are Required for Optimal Antibody Prophylaxis against Pneumocystis carinii Pneumonia","volume":"74","author":"Wells","year":"2005","journal-title":"Infect Immun"},{"issue":"51","key":"10.1016\/j.vaccine.2021.06.001_b0215","article-title":"Fungal Strategies to Evade the Host Immune Recognition","volume":"4","author":"Hernandez-Chavez","year":"2017","journal-title":"J Fungi"},{"key":"10.1016\/j.vaccine.2021.06.001_b0220","doi-asserted-by":"crossref","first-page":"22989","DOI":"10.1038\/srep22989","article-title":"Candida albicans repetitive elements display epigenetic diversity and plasticity","volume":"6","author":"Freire-Benetiez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.06.001_b0225","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.celrep.2018.10.042","article-title":"B Cell Receptor Crosslinking Augments Germinal Center B Cell Selection when T Cell Help is Limiting","volume":"25","author":"Turner","year":"2018","journal-title":"Cell Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:09Z","timestamp":1759402749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":45,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007106"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}